The present study was to see whether echinomycin-induced apoptosis would be NF-κB-dependent and if so, whether echinomycin would activate or inhibit NF-κB as well as resultant chemokine IL-8 expression. In HT-29 cells echinomycin activated NF-κB in time-dependent manner. EMSA in the presence of antibodies specific for p50 and p65 subunits indicated that echinomycin-induces the translocation of p50-p65 heterodimeric subunits of NF-κB. Levels of IκB were detected at initial echinomycin treatment and thereafter decreased, faintly seen after a 6 h treatment. In contrast p-IκB levels were clearly detected throughout 6-24 h of echinomycin treatment, albeit initially fainted. To clarify the role of NF-κB on IL-8 expression in echinomycin-mediated apoptosis of HT-29 cells, ELISA plus RT-PCR clearly showed that IL-8 production is inducible by echinomycin treatment. Using a specific inhibitor, IL-8 regulation at echinomycin treatment in HT-29 cells occurred via both caspase-3 and NF-κB-dependent signal pathway. To confirm whether two different pathways (NF-κB and caspase) would be coupled, only NF-κB inhibitor (PDTC) and caspase-3 specific inhibitor (Z-DEVD-FMK) together significantly attenuated echinomycin-initiated apoptosis of HT-29 cells, pretreatment of HT-29 cells with PDTC rarely affected echinomycin-induced caspase-3 activation. So echinomycin-induced apoptosis in HT-29 cells occurs via NF-κB activation independent of caspase-3 activation modulating the resultant-linked key chemokine IL-8 expression and echinomycin-induced apoptosis is NF-κB-dependant and directly related to NF-κB activation, consequently regulating IL-8 expression.
Bibliographical noteFunding Information:
This work was supported by the academic research grant of Yonsei University College of Medicine for 2005. This study was supported by a grant from the Korea Health 21 R & D Project, Ministry of Health & Welfare, Republic of Korea (A05-0485-AA0718-05N1-00010A).
All Science Journal Classification (ASJC) codes
- Cell Biology